Exon-skipping therapy for Duchenne muscular dystrophy - Authors' reply

Virginia Arechavala-Gomeza; Sebahattin Cirak; Karen Anthony; Jennifer Morgan; Francesco Muntoni

doi:10.1016/S0140-6736(12)60064-6

Exon-skipping therapy for Duchenne muscular dystrophy - Authors' reply

Virginia Arechavala-Gomeza
, Sebahattin Cirak
, Karen Anthony
, Jennifer Morgan
, Francesco Muntoni

Research output: Contribution to Journal › Letter › peer-review

Abstract

A general catalytic procedure for the cycloaddition of diazo amides to fullerene C60 in the presence of the three-component catalyst, Pd(acac)2–PPh3–Et3Al, has been developed. Depending on the reaction conditions, pyrazolinofullerenes or methanofullerenes are formed.

Original language	English
Journal	The Lancet
DOIs	https://doi.org/10.1016/S0140-6736(12)60064-6
Publication status	Published - 14 Jan 2012

Access to Document

10.1016/S0140-6736(12)60064-6

Cite this

@article{118f63dfa3f245578b5953466154f256,

title = "Exon-skipping therapy for Duchenne muscular dystrophy - Authors' reply",

abstract = "A general catalytic procedure for the cycloaddition of diazo amides to fullerene C60 in the presence of the three-component catalyst, Pd(acac)2–PPh3–Et3Al, has been developed. Depending on the reaction conditions, pyrazolinofullerenes or methanofullerenes are formed.",

author = "Virginia Arechavala-Gomeza and Sebahattin Cirak and Karen Anthony and Jennifer Morgan and Francesco Muntoni",

year = "2012",

month = jan,

day = "14",

doi = "10.1016/S0140-6736(12)60064-6",

language = "English",

journal = "The Lancet",

issn = "1474-547X",

publisher = "Elsevier B.V.",

}

TY - JOUR

T1 - Exon-skipping therapy for Duchenne muscular dystrophy - Authors' reply

AU - Arechavala-Gomeza, Virginia

AU - Cirak, Sebahattin

AU - Anthony, Karen

AU - Morgan, Jennifer

AU - Muntoni, Francesco

PY - 2012/1/14

Y1 - 2012/1/14

N2 - A general catalytic procedure for the cycloaddition of diazo amides to fullerene C60 in the presence of the three-component catalyst, Pd(acac)2–PPh3–Et3Al, has been developed. Depending on the reaction conditions, pyrazolinofullerenes or methanofullerenes are formed.

AB - A general catalytic procedure for the cycloaddition of diazo amides to fullerene C60 in the presence of the three-component catalyst, Pd(acac)2–PPh3–Et3Al, has been developed. Depending on the reaction conditions, pyrazolinofullerenes or methanofullerenes are formed.

UR - http://www.mendeley.com/research/exonskipping-therapy-duchenne-muscular-dystrophy-authors-reply

U2 - 10.1016/S0140-6736(12)60064-6

DO - 10.1016/S0140-6736(12)60064-6

M3 - Letter

SN - 1474-547X

JO - The Lancet

JF - The Lancet

ER -

Exon-skipping therapy for Duchenne muscular dystrophy - Authors' reply

Abstract

Access to Document

Other files and links

Fingerprint

Cite this